We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00879125
First Posted: April 9, 2009
Last Update Posted: September 14, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Vanderbilt University
April 8, 2009
April 9, 2009
September 14, 2009
November 1999
November 2007   (Final data collection date for primary outcome measure)
glycemic control [ Time Frame: one year ]
Same as current
Complete list of historical versions of study NCT00879125 on ClinicalTrials.gov Archive Site
Correction of lipid profiles [ Time Frame: one year ]
Same as current
Not Provided
Not Provided
 
Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia
Effect of Gastric Bypass on Type 2 Diabetes and/or Dyslipidemia
This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking at the longer term results after surgery.

Review and record changes in the subject's medication. subjects vitals: weight, blood pressure, and fasting blood values, which include:

  • HbA1c
  • Fasting blood glucose
  • Fasting Insulin
  • Lipid Panel ( total cholesterol, LDL, HDL and triglycerides) were obtained.
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Patients with Type 2 diabetes with a BMI over 35kg/m2
Type 2 Diabetes
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
219
November 2007
November 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

Patients who have had diabetes and/or dyslipidemia prior to gastric by-pass. -

Exclusion Criteria:Patients who have had type 2 diabetes that was diet controlled at time of surgery; and debilitated patients who are unable to come in for a physical exam.

Sexes Eligible for Study: All
17 Years to 66 Years   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00879125
080368
No
Not Provided
Not Provided
Joan Kaiser, RN, Vanderbilt University
Vanderbilt University
Not Provided
Principal Investigator: William O Richards, MD Vanderbilt University Medical Center
Vanderbilt University
September 2009